Global Plasma Fractionation and Blood Product Supply, Demand and Key Producers, 2023-2029

Description

The global Plasma Fractionation and Blood Product market size is expected to reach $ 5961.1 million by 2029, rising at a market growth of 2.7% CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

This report studies the global Plasma Fractionation and Blood Product production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Plasma Fractionation and Blood Product, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Plasma Fractionation and Blood Product that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Plasma Fractionation and Blood Product total production and demand, 2018-2029, (K Units)
Global Plasma Fractionation and Blood Product total production value, 2018-2029, (USD Million)
Global Plasma Fractionation and Blood Product production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Plasma Fractionation and Blood Product consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Plasma Fractionation and Blood Product domestic production, consumption, key domestic manufacturers and share
Global Plasma Fractionation and Blood Product production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Plasma Fractionation and Blood Product production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Plasma Fractionation and Blood Product production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Plasma Fractionation and Blood Product market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Plasma Fractionation and Blood Product market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Plasma Fractionation and Blood Product Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Plasma Fractionation and Blood Product Market, Segmentation by Type
    Coagulation Factor
    Immune Globulin
    Albumin
    Other

Global Plasma Fractionation and Blood Product Market, Segmentation by Application
    Immunology
    Hematology
    Other

Companies Profiled:
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio

Key Questions Answered
1. How big is the global Plasma Fractionation and Blood Product market?
2. What is the demand of the global Plasma Fractionation and Blood Product market?
3. What is the year over year growth of the global Plasma Fractionation and Blood Product market?
4. What is the production and production value of the global Plasma Fractionation and Blood Product market?
5. Who are the key producers in the global Plasma Fractionation and Blood Product market?

Table of Contents

1 Supply Summary
    1.1 Plasma Fractionation and Blood Product Introduction
    1.2 World Plasma Fractionation and Blood Product Supply & Forecast
        1.2.1 World Plasma Fractionation and Blood Product Production Value (2018 & 2022 & 2029)
        1.2.2 World Plasma Fractionation and Blood Product Production (2018-2029)
        1.2.3 World Plasma Fractionation and Blood Product Pricing Trends (2018-2029)
    1.3 World Plasma Fractionation and Blood Product Production by Region (Based on Production Site)
        1.3.1 World Plasma Fractionation and Blood Product Production Value by Region (2018-2029)
        1.3.2 World Plasma Fractionation and Blood Product Production by Region (2018-2029)
        1.3.3 World Plasma Fractionation and Blood Product Average Price by Region (2018-2029)
        1.3.4 North America Plasma Fractionation and Blood Product Production (2018-2029)
        1.3.5 Europe Plasma Fractionation and Blood Product Production (2018-2029)
        1.3.6 China Plasma Fractionation and Blood Product Production (2018-2029)
        1.3.7 Japan Plasma Fractionation and Blood Product Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Plasma Fractionation and Blood Product Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Plasma Fractionation and Blood Product Major Market Trends

2 Demand Summary
    2.1 World Plasma Fractionation and Blood Product Demand (2018-2029)
    2.2 World Plasma Fractionation and Blood Product Consumption by Region
        2.2.1 World Plasma Fractionation and Blood Product Consumption by Region (2018-2023)
        2.2.2 World Plasma Fractionation and Blood Product Consumption Forecast by Region (2024-2029)
    2.3 United States Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.4 China Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.5 Europe Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.6 Japan Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.7 South Korea Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.8 ASEAN Plasma Fractionation and Blood Product Consumption (2018-2029)
    2.9 India Plasma Fractionation and Blood Product Consumption (2018-2029)

3 World Plasma Fractionation and Blood Product Manufacturers Competitive Analysis
    3.1 World Plasma Fractionation and Blood Product Production Value by Manufacturer (2018-2023)
    3.2 World Plasma Fractionation and Blood Product Production by Manufacturer (2018-2023)
    3.3 World Plasma Fractionation and Blood Product Average Price by Manufacturer (2018-2023)
    3.4 Plasma Fractionation and Blood Product Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Plasma Fractionation and Blood Product Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Plasma Fractionation and Blood Product in 2022
        3.5.3 Global Concentration Ratios (CR8) for Plasma Fractionation and Blood Product in 2022
    3.6 Plasma Fractionation and Blood Product Market: Overall Company Footprint Analysis
        3.6.1 Plasma Fractionation and Blood Product Market: Region Footprint
        3.6.2 Plasma Fractionation and Blood Product Market: Company Product Type Footprint
        3.6.3 Plasma Fractionation and Blood Product Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Plasma Fractionation and Blood Product Production Value Comparison
        4.1.1 United States VS China: Plasma Fractionation and Blood Product Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Plasma Fractionation and Blood Product Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Plasma Fractionation and Blood Product Production Comparison
        4.2.1 United States VS China: Plasma Fractionation and Blood Product Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Plasma Fractionation and Blood Product Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Plasma Fractionation and Blood Product Consumption Comparison
        4.3.1 United States VS China: Plasma Fractionation and Blood Product Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Plasma Fractionation and Blood Product Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Plasma Fractionation and Blood Product Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Plasma Fractionation and Blood Product Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023)
    4.5 China Based Plasma Fractionation and Blood Product Manufacturers and Market Share
        4.5.1 China Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Plasma Fractionation and Blood Product Production Value (2018-2023)
        4.5.3 China Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023)
    4.6 Rest of World Based Plasma Fractionation and Blood Product Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023)

5 Market Analysis by Type
    5.1 World Plasma Fractionation and Blood Product Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Coagulation Factor
        5.2.2 Immune Globulin
        5.2.3 Albumin
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Plasma Fractionation and Blood Product Production by Type (2018-2029)
        5.3.2 World Plasma Fractionation and Blood Product Production Value by Type (2018-2029)
        5.3.3 World Plasma Fractionation and Blood Product Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Plasma Fractionation and Blood Product Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Immunology
        6.2.2 Hematology
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Plasma Fractionation and Blood Product Production by Application (2018-2029)
        6.3.2 World Plasma Fractionation and Blood Product Production Value by Application (2018-2029)
        6.3.3 World Plasma Fractionation and Blood Product Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Details
        7.1.2 Takeda Major Business
        7.1.3 Takeda Plasma Fractionation and Blood Product Product and Services
        7.1.4 Takeda Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Takeda Recent Developments/Updates
        7.1.6 Takeda Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Plasma Fractionation and Blood Product Product and Services
        7.2.4 CSL Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 Grifols
        7.3.1 Grifols Details
        7.3.2 Grifols Major Business
        7.3.3 Grifols Plasma Fractionation and Blood Product Product and Services
        7.3.4 Grifols Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Grifols Recent Developments/Updates
        7.3.6 Grifols Competitive Strengths & Weaknesses
    7.4 Octapharma
        7.4.1 Octapharma Details
        7.4.2 Octapharma Major Business
        7.4.3 Octapharma Plasma Fractionation and Blood Product Product and Services
        7.4.4 Octapharma Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Octapharma Recent Developments/Updates
        7.4.6 Octapharma Competitive Strengths & Weaknesses
    7.5 Kedrion
        7.5.1 Kedrion Details
        7.5.2 Kedrion Major Business
        7.5.3 Kedrion Plasma Fractionation and Blood Product Product and Services
        7.5.4 Kedrion Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Kedrion Recent Developments/Updates
        7.5.6 Kedrion Competitive Strengths & Weaknesses
    7.6 LFB Group
        7.6.1 LFB Group Details
        7.6.2 LFB Group Major Business
        7.6.3 LFB Group Plasma Fractionation and Blood Product Product and Services
        7.6.4 LFB Group Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 LFB Group Recent Developments/Updates
        7.6.6 LFB Group Competitive Strengths & Weaknesses
    7.7 Biotest
        7.7.1 Biotest Details
        7.7.2 Biotest Major Business
        7.7.3 Biotest Plasma Fractionation and Blood Product Product and Services
        7.7.4 Biotest Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Biotest Recent Developments/Updates
        7.7.6 Biotest Competitive Strengths & Weaknesses
    7.8 BPL
        7.8.1 BPL Details
        7.8.2 BPL Major Business
        7.8.3 BPL Plasma Fractionation and Blood Product Product and Services
        7.8.4 BPL Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 BPL Recent Developments/Updates
        7.8.6 BPL Competitive Strengths & Weaknesses
    7.9 RAAS
        7.9.1 RAAS Details
        7.9.2 RAAS Major Business
        7.9.3 RAAS Plasma Fractionation and Blood Product Product and Services
        7.9.4 RAAS Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 RAAS Recent Developments/Updates
        7.9.6 RAAS Competitive Strengths & Weaknesses
    7.10 CBPO
        7.10.1 CBPO Details
        7.10.2 CBPO Major Business
        7.10.3 CBPO Plasma Fractionation and Blood Product Product and Services
        7.10.4 CBPO Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 CBPO Recent Developments/Updates
        7.10.6 CBPO Competitive Strengths & Weaknesses
    7.11 Hualan Bio
        7.11.1 Hualan Bio Details
        7.11.2 Hualan Bio Major Business
        7.11.3 Hualan Bio Plasma Fractionation and Blood Product Product and Services
        7.11.4 Hualan Bio Plasma Fractionation and Blood Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Hualan Bio Recent Developments/Updates
        7.11.6 Hualan Bio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Plasma Fractionation and Blood Product Industry Chain
    8.2 Plasma Fractionation and Blood Product Upstream Analysis
        8.2.1 Plasma Fractionation and Blood Product Core Raw Materials
        8.2.2 Main Manufacturers of Plasma Fractionation and Blood Product Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Plasma Fractionation and Blood Product Production Mode
    8.6 Plasma Fractionation and Blood Product Procurement Model
    8.7 Plasma Fractionation and Blood Product Industry Sales Model and Sales Channels
        8.7.1 Plasma Fractionation and Blood Product Sales Model
        8.7.2 Plasma Fractionation and Blood Product Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Plasma Fractionation and Blood Product Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Plasma Fractionation and Blood Product Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Plasma Fractionation and Blood Product Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Plasma Fractionation and Blood Product Production Value Market Share by Region (2018-2023)
    Table 5. World Plasma Fractionation and Blood Product Production Value Market Share by Region (2024-2029)
    Table 6. World Plasma Fractionation and Blood Product Production by Region (2018-2023) & (K Units)
    Table 7. World Plasma Fractionation and Blood Product Production by Region (2024-2029) & (K Units)
    Table 8. World Plasma Fractionation and Blood Product Production Market Share by Region (2018-2023)
    Table 9. World Plasma Fractionation and Blood Product Production Market Share by Region (2024-2029)
    Table 10. World Plasma Fractionation and Blood Product Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Plasma Fractionation and Blood Product Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Plasma Fractionation and Blood Product Major Market Trends
    Table 13. World Plasma Fractionation and Blood Product Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Plasma Fractionation and Blood Product Consumption by Region (2018-2023) & (K Units)
    Table 15. World Plasma Fractionation and Blood Product Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Plasma Fractionation and Blood Product Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Plasma Fractionation and Blood Product Producers in 2022
    Table 18. World Plasma Fractionation and Blood Product Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Plasma Fractionation and Blood Product Producers in 2022
    Table 20. World Plasma Fractionation and Blood Product Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Plasma Fractionation and Blood Product Company Evaluation Quadrant
    Table 22. World Plasma Fractionation and Blood Product Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Plasma Fractionation and Blood Product Production Site of Key Manufacturer
    Table 24. Plasma Fractionation and Blood Product Market: Company Product Type Footprint
    Table 25. Plasma Fractionation and Blood Product Market: Company Product Application Footprint
    Table 26. Plasma Fractionation and Blood Product Competitive Factors
    Table 27. Plasma Fractionation and Blood Product New Entrant and Capacity Expansion Plans
    Table 28. Plasma Fractionation and Blood Product Mergers & Acquisitions Activity
    Table 29. United States VS China Plasma Fractionation and Blood Product Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Plasma Fractionation and Blood Product Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Plasma Fractionation and Blood Product Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Plasma Fractionation and Blood Product Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Plasma Fractionation and Blood Product Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Plasma Fractionation and Blood Product Production Market Share (2018-2023)
    Table 37. China Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Plasma Fractionation and Blood Product Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Plasma Fractionation and Blood Product Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Plasma Fractionation and Blood Product Production Market Share (2018-2023)
    Table 42. Rest of World Based Plasma Fractionation and Blood Product Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production Market Share (2018-2023)
    Table 47. World Plasma Fractionation and Blood Product Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Plasma Fractionation and Blood Product Production by Type (2018-2023) & (K Units)
    Table 49. World Plasma Fractionation and Blood Product Production by Type (2024-2029) & (K Units)
    Table 50. World Plasma Fractionation and Blood Product Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Plasma Fractionation and Blood Product Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Plasma Fractionation and Blood Product Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Plasma Fractionation and Blood Product Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Plasma Fractionation and Blood Product Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Plasma Fractionation and Blood Product Production by Application (2018-2023) & (K Units)
    Table 56. World Plasma Fractionation and Blood Product Production by Application (2024-2029) & (K Units)
    Table 57. World Plasma Fractionation and Blood Product Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Plasma Fractionation and Blood Product Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Plasma Fractionation and Blood Product Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Plasma Fractionation and Blood Product Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Takeda Basic Information, Manufacturing Base and Competitors
    Table 62. Takeda Major Business
    Table 63. Takeda Plasma Fractionation and Blood Product Product and Services
    Table 64. Takeda Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Takeda Recent Developments/Updates
    Table 66. Takeda Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Plasma Fractionation and Blood Product Product and Services
    Table 70. CSL Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. Grifols Basic Information, Manufacturing Base and Competitors
    Table 74. Grifols Major Business
    Table 75. Grifols Plasma Fractionation and Blood Product Product and Services
    Table 76. Grifols Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Grifols Recent Developments/Updates
    Table 78. Grifols Competitive Strengths & Weaknesses
    Table 79. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 80. Octapharma Major Business
    Table 81. Octapharma Plasma Fractionation and Blood Product Product and Services
    Table 82. Octapharma Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Octapharma Recent Developments/Updates
    Table 84. Octapharma Competitive Strengths & Weaknesses
    Table 85. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 86. Kedrion Major Business
    Table 87. Kedrion Plasma Fractionation and Blood Product Product and Services
    Table 88. Kedrion Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Kedrion Recent Developments/Updates
    Table 90. Kedrion Competitive Strengths & Weaknesses
    Table 91. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 92. LFB Group Major Business
    Table 93. LFB Group Plasma Fractionation and Blood Product Product and Services
    Table 94. LFB Group Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. LFB Group Recent Developments/Updates
    Table 96. LFB Group Competitive Strengths & Weaknesses
    Table 97. Biotest Basic Information, Manufacturing Base and Competitors
    Table 98. Biotest Major Business
    Table 99. Biotest Plasma Fractionation and Blood Product Product and Services
    Table 100. Biotest Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Biotest Recent Developments/Updates
    Table 102. Biotest Competitive Strengths & Weaknesses
    Table 103. BPL Basic Information, Manufacturing Base and Competitors
    Table 104. BPL Major Business
    Table 105. BPL Plasma Fractionation and Blood Product Product and Services
    Table 106. BPL Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. BPL Recent Developments/Updates
    Table 108. BPL Competitive Strengths & Weaknesses
    Table 109. RAAS Basic Information, Manufacturing Base and Competitors
    Table 110. RAAS Major Business
    Table 111. RAAS Plasma Fractionation and Blood Product Product and Services
    Table 112. RAAS Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. RAAS Recent Developments/Updates
    Table 114. RAAS Competitive Strengths & Weaknesses
    Table 115. CBPO Basic Information, Manufacturing Base and Competitors
    Table 116. CBPO Major Business
    Table 117. CBPO Plasma Fractionation and Blood Product Product and Services
    Table 118. CBPO Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. CBPO Recent Developments/Updates
    Table 120. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 121. Hualan Bio Major Business
    Table 122. Hualan Bio Plasma Fractionation and Blood Product Product and Services
    Table 123. Hualan Bio Plasma Fractionation and Blood Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Plasma Fractionation and Blood Product Upstream (Raw Materials)
    Table 125. Plasma Fractionation and Blood Product Typical Customers
    Table 126. Plasma Fractionation and Blood Product Typical Distributors
List of Figure
    Figure 1. Plasma Fractionation and Blood Product Picture
    Figure 2. World Plasma Fractionation and Blood Product Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Plasma Fractionation and Blood Product Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Plasma Fractionation and Blood Product Production (2018-2029) & (K Units)
    Figure 5. World Plasma Fractionation and Blood Product Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Plasma Fractionation and Blood Product Production Value Market Share by Region (2018-2029)
    Figure 7. World Plasma Fractionation and Blood Product Production Market Share by Region (2018-2029)
    Figure 8. North America Plasma Fractionation and Blood Product Production (2018-2029) & (K Units)
    Figure 9. Europe Plasma Fractionation and Blood Product Production (2018-2029) & (K Units)
    Figure 10. China Plasma Fractionation and Blood Product Production (2018-2029) & (K Units)
    Figure 11. Japan Plasma Fractionation and Blood Product Production (2018-2029) & (K Units)
    Figure 12. Plasma Fractionation and Blood Product Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 15. World Plasma Fractionation and Blood Product Consumption Market Share by Region (2018-2029)
    Figure 16. United States Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 17. China Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 18. Europe Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 19. Japan Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 22. India Plasma Fractionation and Blood Product Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Plasma Fractionation and Blood Product by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Plasma Fractionation and Blood Product Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Plasma Fractionation and Blood Product Markets in 2022
    Figure 26. United States VS China: Plasma Fractionation and Blood Product Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Plasma Fractionation and Blood Product Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Plasma Fractionation and Blood Product Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Plasma Fractionation and Blood Product Production Market Share 2022
    Figure 30. China Based Manufacturers Plasma Fractionation and Blood Product Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Plasma Fractionation and Blood Product Production Market Share 2022
    Figure 32. World Plasma Fractionation and Blood Product Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Plasma Fractionation and Blood Product Production Value Market Share by Type in 2022
    Figure 34. Coagulation Factor
    Figure 35. Immune Globulin
    Figure 36. Albumin
    Figure 37. Other
    Figure 38. World Plasma Fractionation and Blood Product Production Market Share by Type (2018-2029)
    Figure 39. World Plasma Fractionation and Blood Product Production Value Market Share by Type (2018-2029)
    Figure 40. World Plasma Fractionation and Blood Product Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Plasma Fractionation and Blood Product Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Plasma Fractionation and Blood Product Production Value Market Share by Application in 2022
    Figure 43. Immunology
    Figure 44. Hematology
    Figure 45. Other
    Figure 46. World Plasma Fractionation and Blood Product Production Market Share by Application (2018-2029)
    Figure 47. World Plasma Fractionation and Blood Product Production Value Market Share by Application (2018-2029)
    Figure 48. World Plasma Fractionation and Blood Product Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Plasma Fractionation and Blood Product Industry Chain
    Figure 50. Plasma Fractionation and Blood Product Procurement Model
    Figure 51. Plasma Fractionation and Blood Product Sales Model
    Figure 52. Plasma Fractionation and Blood Product Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio